ST. PAUL, Minn., March 7, 2012 /PRNewswire/ -- Gamma Pharmaceuticals, Inc. (NASDAQ: GMPM.PK) announced today, that Bruce Renick, a senior industry insider, has agreed to join Gamma, initially on the Board of Advisors, later as fulltime Executive Vice President of Sales, once resources permit.  Bruce Renick was most recently the Executive Vice President of Global Sales and Marketing for TwinLab, one of the world's largest vitamin and nutraceutical companies.  At TwinLab, Bruce launched multiple product lines and line extensions and increased margins by revenue stream across product categories. 

Bruce is assisting management to develop and later to drive a more comprehensive sales plan, creating a timeline for product launches and growing the internal functions to make Gamma Pharmaceuticals an industry leader of cutting-edge delivery system technologies in the supplement category. 

Gamma's President, Joe Cunningham commented, "We are happy that Bruce has agreed to join Gamma.  Last autumn, we changed management positions to put more focus on making sales.  If we were missing one person in our management team, it was a true industry sales professional, an experienced insider with retail contacts who can close a sale and execute.  Bruce is that guy." 

About Gamma Pharmaceuticals, Inc.

Gamma Pharmaceuticals, Inc., (www.gammapharma.com) is a marketing and product formulation company selling its own branded products through wholesalers and direct to retailers, both in the US and internationally.  Gamma's core focus is the marketing and sale of vitamins and nutriceuticals, OTC pharmaceutical products and personal care products in the United States.   Branded nutritional supplements are sold under the trademarks Brilliant Choice™ nutritional supplements featuring the call to action "You've made a brilliant choice for your nutrition;" SAVVY™ adult nutritional supplements featuring the call to action, "Be SAVVY Stay Healthy;" and, Gamma Energy Products™ a high performance supplement featuring the call to action, "Get Your Gamma On."  Gamma's customer focus is on selling products in the Lifestyle of Health & Sustainability ("LOHAS") marketplace and in the Energy Supplement Market.  A series of innovative marketing programs support Gamma's product sales and retail partners.  

At present Gamma manufactures in North America, and distributes in the United States. Gamma's products utilize proprietary "Gel Delivery Technology®", to create innovative gel product forms that give consumers a more pleasant experience.  Gel Delivery Technology® characteristics include rapid absorption, convenience and great taste.  Market categories Gamma targets are growing as rapidly as 60% per year.  Gamma has developed formulas and strategies for Metabolic Syndrome and Diabetes Type II, Stress Reduction, Cognition, Well-being, Menopause Symptoms and Personal Care Products. Gamma also develops and manufactures house brands for major retailers.  At this time, Gamma has a total of 36 SKU's and holds licenses for 9 SKUs in China.

Forward-Looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this Press Release regarding any impact the quotation of the Company's stock has on the Pink Sheets or the lack thereof on the OTCBB, and any other effects of the above are forward-looking statements. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

Contact: Gamma Pharmaceuticals, Inc.

Joe Cunningham, President (jcunningham@gammapharma.com)

Direct:  (651) 204 2048

SOURCE Gamma Pharmaceuticals, Inc.